Postoperative mycobacterium abscessus nodular conjunctivitis

Clinical and Experimental Ophthalmology

Volumn 36, Issue 4, 2008, Pages 371-373

  Merani, Rohan ^a,b,c   Orekondy, Sid ^d,e,h   Gottlieb, Thomas ^a   Janarthanan, Perumal ^f   Mccarthy, Stanley ^b,f   Karim, Rooshdiya ^b,f,g   Booth, Frances ^a  

^a Sleep Disorders Unit   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d The Sydney Private Hospital   (Australia)

^e Private Practice   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g CANCER INSTITUTE NSW   (Australia)

^h NONE   (Australia)

Author keywords

Cataract extraction; Eye infection; Mycobacterium

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBOXYMETHYLCELLULOSE; CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DEXAMETHASONE; DICLOFENAC; ERYTHROMYCIN; ETHAMBUTOL; GENTAMICIN; HYDROXYPROPYLMETHYLCELLULOSE; IMIPENEM; OFLOXACIN; OLOPATADINE; PREDNISOLONE ACETATE; RIFAMPICIN; ROXITHROMYCIN; STEROID; TETRACYCLINE;

ACID FAST BACTERIUM; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CATARACT; CONJUNCTIVITIS; CONTROLLED STUDY; EYE BIOPSY; EYE INFECTION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MINIMUM INHIBITORY CONCENTRATION; MORNING DOSAGE; MYCOBACTERIUM ABSCESSUS; OCULAR PRURITUS; PATIENT COMPLIANCE; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; RECOMMENDED DRUG DOSE; RECURRENT INFECTION; SLIT LAMP; VISUAL ACUITY;

AGED; ANTI-BACTERIAL AGENTS; CATARACT EXTRACTION; CIPROFLOXACIN; CLARITHROMYCIN; CONJUNCTIVITIS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ETHAMBUTOL; HUMANS; MALE; MYCOBACTERIUM INFECTIONS, ATYPICAL; POSTOPERATIVE COMPLICATIONS; RECURRENCE;

EID: 47649129690     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01772.x     Document Type: Article

References (10)

1. Brown-elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmented rapidly growing mycobacteria. Clin Microbiol Rev 2002; 15: 716-46.
2. Garg P, Bansal AK, Sharma S, Vemuganti GK. Bilateral infectious keratitis after laser in situ keratomileusis. Ophthalmology 2001; 108: 121-5.
3. Margo CE, Pavan PR. Mycobacterium chelonae conjunctivitis and scleritis following vitrectomy. Arch Ophthalmol 2000; 118: 1125-8.
4. Ford JG, Huang AJW, Pflugfelder SC, Alfonso EC, Forster RK, Miller D. Nontuberculous mycobacterial keratitis in south florida. Ophthalmology 1998; 105: 1652-8.
5. Solomon A, Karp CL, Miller D, Dubovy SR, Huang AJW, Culbertson WW. Mycobacterium interface keratitis after laser in situ keratomileusis. Ophthalmology 2001; 108: 2201-8.
6. Laflamme MY, Poisson M, Chehade N. Mycobacterium chelonae keratitis following penetrating keratoplasty. Can J Ophthalmol 1987; 22: 178-80.
7. Scott IU, Lieb DF, Flynn HW Jr, Dessouki A, Murray TG, Miller D. Endophthalmitis caused by mycobacterium chelonae: Selection of antibiotics and outcomes of treatment. Arch Ophthalmol 2003; 121: 573-6.
8. Smiddy WE, Miller D, Flynn HW Jr. Scleral buckle infections due to atypical mycobacteria. Retina 1991; 11: 394-8.
9. Rootman DS, Insler MS, Wolley DE. Canaliculitis caused by Mycobacterium chelonae after lacrimal intubation with silicone tubes. Can J Ophthalmol 1989; 24: 221-2.
10. Chang WJ, Tse DT, Rosa RH, Miller D. Periocular atypical mycobacterial infections. Ophthalmology 1999; 106: 86-90.